Surge in Call Option Activity for Sun Pharmaceutical at Rs 1700 Strike Price
Sun Pharmaceutical Industries Ltd is witnessing increased activity in the options market, particularly with call options expiring on August 28, 2025. Significant trading volumes have been recorded across various strike prices, while the stock is currently trading below its key moving averages, indicating a challenging market environment.
Sun Pharmaceutical Industries Ltd has emerged as one of the most active stocks today, particularly in the options market. The company, operating within the Pharmaceuticals & Biotechnology sector, has seen significant trading activity in call options set to expire on August 28, 2025. Notably, the call option with a strike price of Rs 1700 led the activity with 8,209 contracts traded, resulting in a turnover of Rs 540.44 lakhs and an open interest of 2,164 contracts. Other active strike prices included Rs 1660 with 4,244 contracts traded and a turnover of Rs 477.26 lakhs, and Rs 1800 with 5,261 contracts traded, contributing Rs 96.86 lakhs to the turnover.
The underlying value of Sun Pharma is currently Rs 1644.8, which is approximately 4.53% away from its 52-week low of Rs 1553.05. The stock has underperformed its sector by 3.35% today, with a 1-day return of -3.77%. It has been on a downward trend, losing 6.18% over the past two days. The stock's performance metrics indicate it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, reflecting a challenging market position.
In summary, Sun Pharmaceutical Industries Ltd is experiencing heightened activity in its options market, with notable trading volumes and a significant open interest, amidst a backdrop of recent price declines and underperformance relative to its sector.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
